[{"address1": "Room 325, 55 Claverick Street", "city": "Providence", "state": "RI", "zip": "02903", "country": "United States", "phone": "401 444 7375", "website": "https://www.oceanbiomedical.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Elizabeth  Ng M.B.A.", "age": 66, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Inderjote  Kathuria M.B.A., M.D.", "age": 56, "title": "Chief Strategy Officer", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chirinjeev Baboo Kathuria M.B.A., M.D.", "age": 58, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack A. Elias M.D.", "age": 72, "title": "Founder, Chairman of Scientific Advisory Board & Independent Director", "yearBorn": 1951, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jonathan  Kurtis M.D., Ph.D.", "age": 54, "title": "Founder, Chairman of Scientific Advisory Board & Director", "yearBorn": 1969, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert John Sweeney", "age": 58, "title": "Chief Accounting Officer & Assistant Secretary", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 4.04, "open": 3.9, "dayLow": 3.7643, "dayHigh": 5.75, "regularMarketPreviousClose": 4.04, "regularMarketOpen": 3.9, "regularMarketDayLow": 3.7643, "regularMarketDayHigh": 5.75, "beta": 0.952, "forwardPE": -5.9213486, "volume": 13050216, "regularMarketVolume": 13050216, "averageVolume": 6694171, "averageVolume10days": 38979780, "averageDailyVolume10Day": 38979780, "bid": 5.29, "ask": 5.2, "bidSize": 1100, "askSize": 800, "marketCap": 179639536, "fiftyTwoWeekLow": 0.52, "fiftyTwoWeekHigh": 12.08, "fiftyDayAverage": 0.96844, "twoHundredDayAverage": 2.925655, "currency": "USD", "enterpriseValue": 149592976, "floatShares": 3153185, "sharesOutstanding": 34087200, "sharesShort": 909832, "sharesShortPriorMonth": 898414, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.026700001, "heldPercentInsiders": 0.73175, "heldPercentInstitutions": 0.13727, "shortRatio": 9.69, "shortPercentOfFloat": 0.0943, "impliedSharesOutstanding": 34087200, "bookValue": -0.247, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -85080000, "trailingEps": -2.55, "forwardEps": -0.89, "52WeekChange": -0.61742425, "SandP52WeekChange": 0.30279303, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "OCEA", "underlyingSymbol": "OCEA", "shortName": "Ocean Biomedical, Inc.", "longName": "Ocean Biomedical, Inc.", "firstTradeDateEpochUtc": 1636381800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "3912ca55-c0cf-3bf3-81ae-9047b9a5b9b3", "messageBoardId": "finmb_669640055", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.27, "targetHighPrice": 18.5, "targetLowPrice": 16.4, "targetMeanPrice": 17.45, "targetMedianPrice": 17.45, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 1161000, "totalCashPerShare": 0.034, "totalDebt": 13096000, "quickRatio": 0.044, "currentRatio": 0.081, "operatingCashflow": -7908000, "financialCurrency": "USD", "trailingPegRatio": null}]